← FDA Drug Approvals (Drugs@FDA)

IRON SUCROSE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: INTL MEDICATION SYS · Approved 2025-08-08

Drug application

FDA Application #
ANDA208977
Application type
Abbreviated New Drug Application (Generic)
Brand name
IRON SUCROSE
Generic name
IRON SUCROSE
Active ingredients
IRON SUCROSE
Dosage form
INJECTABLE
Route
INTRAVENOUS
Marketing status
Prescription
Sponsor
INTL MEDICATION SYS
Manufacturer
International Medication Systems, Limited
First approval
2025-08-08

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown